Calcium Channel Blockers Vs Other Classes of Antihypertension Drugs
A meta-analysis found mixed evidence that CCBs are superior or inferior to any specific other antihypertensive drug at reducing major CV events.
Source: endocrinologyadvisor.com
Page 27 - Controlled Trials News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Controlled Trials. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Controlled Trials Today - Breaking & Trending Today
Intensive statin based LDL-C lowering helps prevent recurrence of ischemic stroke: JAMA
Taiwan: A recent study published in the Journal of American Medical Association - Neurology pointed out that, more intensive LDL-C–lowering statin-based therapies might be warranted for patients with...
Source: medicaldialogues.in
Combination Antidepressant Treatment Outperforms Monotherapy
Combining a reuptake inhibitor with presynaptic alpha2-autoreceptors significantly improves treatment outcomes for depression vs monotherapy, a meta-analysis suggests.
Source: medscape.com
Oral fexinidazole cost-effective treatment of human African trypanosomiasis: Study
Oral fexinidazole was found to be both convenient and cost-effective treatment for patients with stage II gambiense human African trypanosomiasis (g-HAT), in systematic review. However it may be...
Source: medicaldialogues.in
Can Practice Guidelines for COVID-19 Inpatient Drug Therapies Be Trusted?
Few clinical practice guidelines for drug treatments used for inpatients with COVID-19 are “trustworthy” by National Academy of Medicine standards.
Source: neurologyadvisor.com